We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Illumina, Inc.

The stock's rise snapped a four-day losing streak.

Amid increasing economic tensions with the United States, China recently announced that it would ban Illumina, a U.S.-based company and the ...

The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

RBC Capital lowered the firm’s price target on Illumina (ILMN) to $128 from $247 but keeps an Outperform rating on the shares. The company’s ...

In a report released yesterday, Conor McNamara from RBC Capital maintained a Buy rating on Illumina (ILMN – Research Report), with a price ...

However, over the past two decades, the country has also invested in building a competitive biotechnology sector. Given its limited domestic market but strong infrastructure in manufacturing, research ...

Illumina has been barred from exporting its DNA sequencers to China, which closed its doors to the company in response to the Trump administration expanding its tariffs on the country. Previously ...

Additionally, Illumina — alongside the rest of the biotech industry — is facing uncertainty amidst looming cuts to research funding and grants, primarily from the National Institutes of Health ...

China’s Ministry of Commerce said it would ban Illumina, a San Diego company, from importing its gene-mapping products in China. Illumina is the world’s leading producer of gene-sequencing ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. Today, we talk about the likely confirmation of FDA nominee ...

Rise and shine, everyone, another busy day is on the way. We can tell by the growing number of motor vehicles passing by the Pharmalot campus and the continuous rumble of commuter trains off in ...